{"CONCEPT_ID":[1344354],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["epirubicin"],"NUM_PERSONS":[2],"PERCENT_PERSONS":["0.0017"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"FEMALE","MIN_VALUE":34,"P10_VALUE":34,"P25_VALUE":34,"MEDIAN_VALUE":34,"P75_VALUE":67,"P90_VALUE":67,"MAX_VALUE":67}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"60-69","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2016,"Y_PREVALENCE_1000PP":16.3934},{"TRELLIS_NAME":"30-39","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2017,"Y_PREVALENCE_1000PP":20.8333}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":201609,"Y_PREVALENCE_1000PP":0.9766},{"X_CALENDAR_MONTH":201711,"Y_PREVALENCE_1000PP":0.9747}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":143,"P10_VALUE":143,"P25_VALUE":143,"MEDIAN_VALUE":143,"P75_VALUE":143,"P90_VALUE":143,"MAX_VALUE":143}]}
